A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis

NCT01543191 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: PUR118

Sponsor

Pulmatrix Inc.

Collaborators

[object Object]